David A. Betebenner

2.4k total citations
23 papers, 800 citations indexed

About

David A. Betebenner is a scholar working on Infectious Diseases, Organic Chemistry and Molecular Biology. According to data from OpenAlex, David A. Betebenner has authored 23 papers receiving a total of 800 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 14 papers in Organic Chemistry and 11 papers in Molecular Biology. Recurrent topics in David A. Betebenner's work include HIV/AIDS drug development and treatment (16 papers), Click Chemistry and Applications (12 papers) and HIV Research and Treatment (9 papers). David A. Betebenner is often cited by papers focused on HIV/AIDS drug development and treatment (16 papers), Click Chemistry and Applications (12 papers) and HIV Research and Treatment (9 papers). David A. Betebenner collaborates with scholars based in United States, United Kingdom and Hungary. David A. Betebenner's co-authors include Hing L. Sham, Dale J. Kempf, Daniel W. Norbeck, Jacob J. Plattner, Ayda Saldivar, Norman E. Wideburg, Sudthida Vasavanonda, Chen Zhao, David G. Nettesheim and Stephen W. Fesik and has published in prestigious journals such as Biochemical and Biophysical Research Communications, FEBS Letters and Journal of Medicinal Chemistry.

In The Last Decade

David A. Betebenner

23 papers receiving 769 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David A. Betebenner United States 15 368 348 195 128 101 23 800
John Deadman United Kingdom 21 508 1.4× 437 1.3× 216 1.1× 76 0.6× 170 1.7× 67 1.0k
Hiromu Habashita Japan 19 555 1.5× 737 2.1× 117 0.6× 80 0.6× 125 1.2× 45 1.2k
Wolfgang von der Saal Germany 16 423 1.1× 357 1.0× 113 0.6× 96 0.8× 50 0.5× 35 959
Rajeshri G. Karki United States 17 420 1.1× 299 0.9× 283 1.5× 106 0.8× 226 2.2× 25 778
Maha Kosa United States 6 284 0.8× 315 0.9× 282 1.4× 98 0.8× 170 1.7× 9 837
Michèle Reboud‐Ravaux France 17 312 0.8× 358 1.0× 237 1.2× 43 0.3× 219 2.2× 45 789
Björn Classon Sweden 21 727 2.0× 763 2.2× 370 1.9× 124 1.0× 201 2.0× 67 1.3k
David A. DeGoey United States 12 354 1.0× 246 0.7× 240 1.2× 184 1.4× 71 0.7× 26 867
Linda S. Payne United States 12 520 1.4× 429 1.2× 453 2.3× 87 0.7× 359 3.6× 19 1.1k
James E. Fritz United States 9 491 1.3× 559 1.6× 207 1.1× 74 0.6× 148 1.5× 12 914

Countries citing papers authored by David A. Betebenner

Since Specialization
Citations

This map shows the geographic impact of David A. Betebenner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Betebenner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Betebenner more than expected).

Fields of papers citing papers by David A. Betebenner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Betebenner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Betebenner. The network helps show where David A. Betebenner may publish in the future.

Co-authorship network of co-authors of David A. Betebenner

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Betebenner. A scholar is included among the top collaborators of David A. Betebenner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Betebenner. David A. Betebenner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krueger, A. Chris, Darold L. Madigan, David W. A. Beno, et al.. (2012). Novel Hepatitis C virus replicon inhibitors: Synthesis and structure–activity relationships of fused pyrimidine derivatives. Bioorganic & Medicinal Chemistry Letters. 22(6). 2212–2215. 25 indexed citations
2.
3.
Petros, Andrew M., Jürgen Dinges, David J. Augeri, et al.. (2005). Discovery of a Potent Inhibitor of the Antiapoptotic Protein Bcl-x L from NMR and Parallel Synthesis. Journal of Medicinal Chemistry. 49(2). 656–663. 229 indexed citations
4.
Sham, Hing L., David A. Betebenner, William Rosenbrook, et al.. (2004). Novel lopinavir analogues incorporating heterocyclic replacements of six-member cyclic urea––synthesis and structure–activity relationships. Bioorganic & Medicinal Chemistry Letters. 14(10). 2643–2645. 15 indexed citations
5.
Sham, Hing L., Chen Zhao, Leping Li, et al.. (2003). Novel Lopinavir Analogues Incorporating Non‐aromatic P‐1 Side Chains — Synthesis and Structure—Activity Relationships.. ChemInform. 34(8). 1 indexed citations
6.
Sham, Hing L., David A. Betebenner, Xiaoqi Chen, et al.. (2002). Synthesis and structure–activity relationships of a novel series of HIV-1 protease inhibitors encompassing ABT-378 (Lopinavir). Bioorganic & Medicinal Chemistry Letters. 12(8). 1185–1187. 14 indexed citations
7.
Hajduk, Philip J., Suzanne B. Shuker, David G. Nettesheim, et al.. (2002). NMR-Based Modification of Matrix Metalloproteinase Inhibitors with Improved Bioavailability. Journal of Medicinal Chemistry. 45(26). 5628–5639. 49 indexed citations
8.
Sham, Hing L., Chen Zhao, Leping Li, et al.. (2002). Novel lopinavir analogues incorporating non-Aromatic P-1 side chains—Synthesis and structure–Activity relationships. Bioorganic & Medicinal Chemistry Letters. 12(21). 3101–3103. 41 indexed citations
9.
Sham, Hing L., David A. Betebenner, Thomas Herrin, et al.. (2001). Synthesis and antiviral activities of the major metabolites of the HIV protease inhibitor ABT-378 (Lopinavir). Bioorganic & Medicinal Chemistry Letters. 11(11). 1351–1353. 15 indexed citations
10.
Kumar, Gondi, Ronald Lee, David N. Whittern, et al.. (1999). In Vitro Metabolism of the HIV-1 Protease Inhibitor ABT-378: Species Comparison and Metabolite Identification. Drug Metabolism and Disposition. 27(1). 86–91. 51 indexed citations
11.
Kempf, Dale J., Hing L. Sham, Kennan C. Marsh, et al.. (1998). Discovery of Ritonavir, a Potent Inhibitor of HIV Protease with High Oral Bioavailability and Clinical Efficacy. Journal of Medicinal Chemistry. 41(4). 602–617. 145 indexed citations
12.
Sham, Hing L., Chen Zhao, Kennan C. Marsh, et al.. (1996). Novel Azacyclic Ureas That Are Potent Inhibitors of HIV-1 Protease. Biochemical and Biophysical Research Communications. 225(2). 436–440. 6 indexed citations
13.
Sham, Hing L., Chen Zhao, Kennan C. Marsh, et al.. (1995). Potent Inhibitors of the HIV-1 Protease with Good Oral Bioavailabilities. Biochemical and Biophysical Research Communications. 211(1). 159–165. 6 indexed citations
14.
Sham, Hing L., William Rosenbrook, Warren M. Kati, et al.. (1995). Potent inhibitor of the human rhinovirus (HRV) 3C protease containing a backbone modified glutamine. Journal of the Chemical Society Perkin Transactions 1. 1081–1081. 12 indexed citations
15.
Sham, Hing L., David A. Betebenner, Chen Zhao, et al.. (1993). Facile synthesis of potent HIV-1 protease inhibitors containing a novel pseudo-symmetric dipeptide isostere. Journal of the Chemical Society Chemical Communications. 1052–1052. 13 indexed citations
16.
Sham, Hing L., David A. Betebenner, Norman E. Wideburg, et al.. (1993). Pseudo‐symmetrical difluoroketones. FEBS Letters. 329(1-2). 144–146. 12 indexed citations
17.
Sham, Hing L., David A. Betebenner, Norman E. Wideburg, et al.. (1991). Potent HIV-1 protease inhibitors with antiviral activities in vitro. Biochemical and Biophysical Research Communications. 175(3). 914–919. 17 indexed citations
18.
19.
20.
Sham, Hing L., Norman E. Wideburg, Stephen G. Spanton, et al.. (1991). Synthesis of (2S,5S,4R)-2,5-diamino-3,3-difluoro-1,6-diphenylhydroxyhexane: the core unit of a potent HIV proteinase inhibitor. Journal of the Chemical Society Chemical Communications. 110–110. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John Deadman Breakdown of academic impact, for papers by Hiromu Habashita Breakdown of academic impact, for papers by Wolfgang von der Saal Breakdown of academic impact, for papers by Rajeshri G. Karki Breakdown of academic impact, for papers by Maha Kosa Breakdown of academic impact, for papers by Michèle Reboud‐Ravaux Breakdown of academic impact, for papers by Björn Classon Breakdown of academic impact, for papers by David A. DeGoey Breakdown of academic impact, for papers by Linda S. Payne Breakdown of academic impact, for papers by James E. Fritz
Rankless by CCL
2026